Clinical trials for drug repositioning aim at evaluating the effectiveness and safety of existing drugs as new treatments. This involves managing and semantically correlating many interdependent parameters and details in order to clearly identify the research question of the clinical trial. This work, which is carried out within the PONTE (Efficient Patient Recruitment for Innovative Clinical Trials of Existing Drugs) project, aims to improve the trial design process, by not only offering access to a variety of relevant data sourcesincluding, but not limited to, drug profiles, diseases and their mechanisms, genes and past trial results -but also providing the ability to navigate through these sources, perform queries on them and intelligently fuse the available information through semantic reasoning. This article describes our intention to consume and aggregate information from Linked Data sources in order to produce answers for the clinical researcher's questions.
INTRODUCTION
Clinical research, including investigation of the test of hypothesis, clinical trial design and study conduction, comprises an expensive and very important part of the R&D activities of the pharmaceutical companies. Trials for drug repositioning, which aim at testing established compounds to new medical conditions, appear to gain ground as their compounds have already been found safe in clinical trials and sometimes are already present in the market. Although the uncertainty of safety is lower in such trials, still problematic situations -for example an adverse effect of a drug compound -present important risks (Ashburn, 2004) . In many cases evidence of such issues already exists in published scientific literature and other clinical information sources but is often difficult to discover and/or correlate, given the volume, variety and distributed nature of the information required.
Scientific results from medical research, including those from clinical trials, are gradually being published as Linked Open Data (LOD) (Bizer, 2010) . Although not many of the available clinical data sources are available as Linked Data, there is a good and growing representation that can be used for the purposes of the PONTE project (Chondrogiannis, 2011) . This rapidly growing collection of well-structured (using RDF and OWL) and easily accessible (using HTTP) data (BernersLee, 2006) contains clinical information about drugs and their side effects, clinical trials, diseases and their mechanisms (pathophysiology) and other aspects of the domain. These data sources comprise a valuable source for clinical research but more importantly, because of their structure and links, they can be used by search tools to produce search results that are otherwise hard or impossible to come across.
The idea of deploying semantic web technologies for querying and creating links between data sources for enabling automatic knowledge aggregation is an area of scientific research that several projects are exploring and developing technologies and tools for. The Bio2RDF project has created a framework that provides on demand data for mash-ups in the bioinformatics domain (Belleau, 2008) . There are projects that have investigated several techniques on querying the Linked Data cloud (Bouquet, 2009) , (Hartig, 2012) . The FedBench project (Schmidt, 2011) has produced a benchmark framework for analysing the efficiency and performance of different strategies for federated query processing on semantic data. In this paper we will explain the benefits of our semantic search approach that aims at assisting the design of clinical trials on existing drugs by discovering semantic associations within the Linked Data sources.
INCORPORATION AND AGGREGATION OF LINKED DATA SOURCES
During clinical research different parameters about drugs, diseases, trial targets (genes, proteins) are assessed and carefully examined. This information is dispersed in different data sources created autonomously by often-unassociated institutional bodies, then -some of it -republished as Linked Data (Samwald, 2011) . In order to effectively use the knowledge existing within these sources we need to combine the information available. For instance, the information about the possible disease targets of a given drug can be found in the DrugBank Linked Data source. However, the information about the genes associated with a specific disorder is found in Diseasome Linked Data source. Thanks to the SPARQL endpoints we are able to collect the information from all these sources. This would otherwise be a quite difficult task with only the upstream data sources, since we would have to overcome a variety of problems, including the database technology, the various structure logics and the way information is represented.
Additionally we have chosen to use the ontologies of some of the above data sources for describing the query term, defining its domain (by using a taxonomy graph) and the data aggregation options for presenting the information. The domain taxonomy graph is composed using Construct queries on the ontology of the term, while the related concepts graph is constructed by using the RDF links and relations between the query term and concepts or instances found in the other domain ontologies. For reasons of availability and performance of the system the ontologies are hosted in an RDF repository, which is part of the Ontology Management component (see figure 1 ) and are made available to PONTE components through a SPARQL endpoint inside a common and closed network.
The Linked Data Application and Query Engine
The Linked Data Application (LDApp) is part of a software framework created in the context of PONTE project (Chondrogiannis, 2011) . Its primary function is to assist the investigation on a drug, its target, and study disorder. The LDApp is a web application that dynamically generates a data aggregation of information retrieved from the PONTE platform -more specifically from the Ontology Management component -and the Linked Open Data Cloud. The LDApp uses the SPARQL query language for RDF to retrieve RDF Graphs from the Ontology Management component and to query the Linked Data sources. In terms of the LDApp interfacing with the other components of the platform, the queries that are generated from these components contain information that associates the search term with the domain of the question. Using this information, the main term or concept of the query is linked with a concept from the respective Ontology. The interactions between the LDApp, the PONTE components and the Linked Data sources are presented in the sequence diagram in Figure 1 . The LDApp requests from the RDF repository of the Ontology Management component the related concepts of the domain ontologies. It then constructs a graph that is composed of concepts and instances representing the taxonomy and relevant information of the query's main term. The graph concepts and instances additionally contain relations and RDF links to the web of Linked Data sources, which can be used to execute queries across multiple data sources. The graph is visualized by the LDApp and can be used to assist the answering of research questions by providing options to expand or filter the query results.
The LDApp can perform additional queries to retrieve data for constructing a Linked Data mashup. These queries to Linked Data sources are performed via the PONTE Query Engine. The Query Engine is a SPARQL endpoint that is able to execute queries across multiple data sources and for the purposes of this prototype implementation, its developments are based on the SQUIN library that supports link traversal based query execution (Hartig, 2009 ). The left frame contains the domain graph that is compiled from ontologies covering three domains: disease, drug and drug target. The right frame mainly contains the query results and mechanisms to assist the user's search and navigation through them. In the example depicted in this figure, the term that a clinician is interested in is the "Myocardial Infarction" and the domain is a graph based on the Disease concept of the Diseasome ontology. The results of DESCRIBE queries are presented to the users of LDApp at their original form (as pictured in figure 2) ; SELECT queries are presented using an RSS style (Figure 3 ) with the title, link and description of each data item.
Answering Hypothesis Questions
In order to demonstrate the benefits of using the LDApp, we will use an example that is based on one of the PONTE use cases. We assume that the clinician's question is about clinical trials on the disease "Myocardial Infarction". Initially results for this disease are retrieved from the resource "Myocardial Infarction" of LD source Diseasome (see Figure 2) .
The Diseasome resource has a list of diseasome:possibleDrug properties pointing to drug resources in DrugBank and DailyMed LD sources. Other links include a list of genes responsible for the syndrome and owl:sameAs pointers to other data sources. By selecting one of these properties (RDF links) the clinician is effectively constructing queries to Linked Data sources. For example s/he is interested in possible drugs against the disease (diseasome:possibleDrugs), so s/he selects "possibleDrugs" from the expansion list (of figure  2) , which triggers a dynamically created query, which in this example is the following: Figure 3 shows how the results of this query are presented in the LDApp. For example, the drug Etanercept is among the results of the above query along with data linked to it such as its description, indications, other diseases for which it can be used as treatment, clinical trials, side effects and much more. This additional information on each of the resulting items is presented to the clinician on the right frame of LDApp when s/he clicks on its title of the item. Additionally, the left frame presents the "Etarnecept" instance in the DrugBank ontology again with some expansion options. The clinician can continue her/his search and choose an owl:sameAs expansion; results from several Linked Data sources are returned that can be of great interest to the specification of study parameters: such as from SIDER, a source for side effects and from ClinicalTrial.gov (LinkedCT Linked Data source) with descriptions on past clinical trials of this drug. Hence, this process can facilitate the clinician's work in finding/extracting the information that s/he needs.
CONCLUSIONS AND FUTURE WORK
In this article, we presented a prototype application that consumes Linked Data for assisting the design process of drug repositioning clinical trials. We have explained our approach for aggregating information from heterogeneous data sources by exploiting the links between them, which allows navigation and performing queries across different data sources, and by assisting users to navigate from one topic (data source) to another using the ontology based navigation frame. In order to demonstrate the capability of answering research questions for the test of hypothesis and study parameters specification we have developed a scenario in which the Linked Data Application (LDApp) provides initial results and then extends clinical researcher's search requests using the Web of Linked Data. We have plans to extend the use of Linked Data Application and Query Engine to other processes of the PONTE platform such as the validation of the clinical trial protocol and the proposing of eligibility criteria. We are also looking at further improving the query engine and especially developing a "query expansion" mechanism. This mechanism aims at reformulating a seed query to improve retrieval performance in information retrieval operations (Hartig, 2012) and, in the context of semantic data, it will involve performing additional searches in semantically associated data sources.
